FDA 483 - Hach Co - April 01, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Hach Co in Ames, IA, identified a significant deficiency in the firm's corrective and preventive action (CAPA) procedures. The company failed to adequately address ongoing and recurring complaints regarding a speaker error in its CM 130 ultra-low chlorine analyzer, a device used for dialysis treatment. Despite a previous field action and numerous subsequent complaints, no additional corrective actions were initiated, indicating a systemic breakdown in their quality management system.
- Person
ID · b2290bb3-3824-4337-87e3-ffdc6e960509